American Journal of Hematology · 1997 · 71 citations · 12 references
Veterinary MedicineHematologyInfectious DiseasesClinical ImmunologyImmunopathologyParasite ImmunologyBlood ParasitesMalariaPlatelet DisordersPlatelet PhysiologyAntibodiesAntimalarial AgentsImmune-mediated ThrombocytopeniaImmunological MechanismsImmunopathology Of MalariaMalaria ImmunologyPlasmodium FalciparumPlasmodium Vivax
Case 1: A 27-year-old woman, referred to our hospital because of relapsing fever after travel to Thailand, was given a diagnosis of vivax malaria. Clinical investigation revealed thrombocytopenia, elevated platelet-associated IgG (PAIgG), and negative antibody against Plasmodium vivax antigen. After antimalarial treatment, the levels of both the platelets and PAIgG returned to normal. Case 2: A 28-year-old Sri Lankan man was admitted to our hospital with a complaint of fever. The patient had thrombocytopenia, elevated PAIgG, and positive antibody against Plasmodium vivax antigen. He contracted malaria in Sri Lanka about 6 months prior to this admission. After treatment, the platelet count and PAIgG level returned to normal. In these two cases, high levels of PAIgG may have been involved in the development of the thrombocytopenia. In the first patient, in particular, the thrombocytopenia was thought to be induced by some immunological mechanism prior to the detection of antimaralial antibodies in serum.
12
Immune-mediated thrombocytopenia of malaria.
John G. Kelton, Jay Keystone, J Moore et al. · Journal of Clinical Investigation · 1983 · 158 citations · Full text
Depletion of coagulation factors in drug-resistant Plasmodium falciparum malaria.
Lewis H. Dennis, James W. Eichelberger, Max M. Inman et al. · PubMed · 1967 · 138 citations
Mechanisms of Thrombocytopenia in Malignant Tertian Malaria
R. B. Skudowitz, J. Katz, A. Lurie et al. · BMJ · 1973 · 125 citations · Full text